Work

Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities—Phase III Studies

Year: 2019

Type: article

Abstract: Significant advances continue in the development of cancer-specific molecular imaging agents and modalities for diagnosing, staging, and treating various cancer types. For these advances to translate successfully to widespread clinical use, both regulatory approval by the U.S. Food and Drug

Source: Journal of Nuclear Medicine

DOI: 10.2967/jnumed.118.219824

Authors: Sanjiv S. Gambhir, Lalitha K. Shankar, Eben Rosenthal, Jason M. Warram, Munir Ghesani, Thomas A. Hope, Paula M. Jacobs, Gunilla B. Jacobson, Terri Wilson, Barry A. Siegel

Institutions: Stanford Medicine, Stanford University, National Cancer Institute, University of Alabama at Birmingham, New York University, University of California, San Francisco, Washington University in St. Louis

Language: English

Topic: Medical Imaging Techniques and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2920937965

FWCI: 0.992

Cites: 45

Cited by: 7

Related to: 10